SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001940272-24-000004
Filing Date
2024-07-09
Accepted
2024-07-09 20:29:48
Documents
1
Period of Report
2024-06-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 4460
  Complete submission text file 0001940272-24-000004.txt   6721
Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-649-9272
Acasti Pharma Inc. (Issuer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 325 RANCH ROAD 620 SOUTH, SUITE 200 AUSTIN TX 78738
Business Address 325 RANCH ROAD 620 SOUTH, SUITE 200 AUSTIN TX 78738 512-531-9088
ADAR1 Partners, LP (Reporting) CIK: 0001758866 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35776 | Film No.: 241108483

Mailing Address 3503 WILD CHERRY DRIVE BUILDING 9 AUSTIN TX 78738
Business Address 3503 WILD CHERRY DRIVE BUILDING 9 AUSTIN TX 78738 512-254-3790
ADAR1 Capital Management, LLC (Reporting) CIK: 0001940272 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35776 | Film No.: 241108484